Literature DB >> 12447729

Central nervous system apoptosis in human herpes simplex virus and cytomegalovirus encephalitis.

Roberta L DeBiasi1, B K Kleinschmidt-DeMasters, Sarah Richardson-Burns, Kenneth L Tyler.   

Abstract

Central nervous system (CNS) specimens from 10 immunocompetent patients with herpes simplex encephalitis (HSE) and 3 infants with congenital cytomegalovirus (CMV) encephalitis were analyzed to determine whether apoptosis is a feature of CNS injury in these patients. Apoptotic neurons and glia were detected in significant numbers in acute HSE and CMV encephalitis. Occurring predominantly in areas of productive viral infection, apoptosis appeared to result from direct viral injury to neurons and was not dependent on inflammatory T cell responses. In contrast to patients with acute cases, patients with late sequelae of HSE or CMV had no detectable virus and minimal neuronal or glial apoptosis, regardless of the degree of inflammation. This is the first demonstration of apoptotic neuronal death in humans with HSE. These results suggest that neuronal apoptosis is an important contributing factor to acute CNS injury and may serve as a novel therapeutic target in these patients.

Entities:  

Mesh:

Year:  2002        PMID: 12447729     DOI: 10.1086/345375

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  Viral mitochondria-localized inhibitor of apoptosis (UL37 exon 1 protein) does not protect human neural precursor cells from human cytomegalovirus-induced cell death.

Authors:  Richard L Hildreth; Matthew D Bullough; Aiping Zhang; Hui-Ling Chen; Philip H Schwartz; David M Panchision; Anamaris M Colberg-Poley
Journal:  J Gen Virol       Date:  2012-08-08       Impact factor: 3.891

2.  Caspase-3 activation is required for reovirus-induced encephalitis in vivo.

Authors:  J David Beckham; Kathryn D Tuttle; Kenneth L Tyler
Journal:  J Neurovirol       Date:  2010-07       Impact factor: 2.643

3.  Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase.

Authors:  J David Beckham; Robin J Goody; Penny Clarke; Christophe Bonny; Kenneth L Tyler
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

4.  An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.

Authors:  Olus Uyar; Nataly Laflamme; Jocelyne Piret; Marie-Christine Venable; Julie Carbonneau; Karima Zarrouk; Serge Rivest; Guy Boivin
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

Review 5.  Apoptosis in animal models of virus-induced disease.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

6.  Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle.

Authors:  Guey-Chuen Perng; Clinton Jones
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-15

7.  Reovirus activates transforming growth factor beta and bone morphogenetic protein signaling pathways in the central nervous system that contribute to neuronal survival following infection.

Authors:  J David Beckham; Kathryn Tuttle; Kenneth L Tyler
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

8.  Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.

Authors:  Roberta L DeBiasi; Bridget A Robinson; Barbara Sherry; Ron Bouchard; R Dale Brown; Mona Rizeq; Carlin Long; Kenneth L Tyler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Host strain-dependent difference in susceptibility in a rat model of herpes simplex type 1 encephalitis.

Authors:  Biborka Bereczky-Veress; Olle Lidman; Farideh Sabri; Ivan Bednar; Fredrik Granath; Tomas Bergström; Christian Spenger; Alf Grandien; Tomas Olsson; Fredrik Piehl; Margarita Diez; Birgit Sköldenberg
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

Review 10.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.